New inhaled COVID-19 vaccines begin human trials at McMaster University - The Globe and Mail

Timothy Moore

Published December 7, 2021Updated December 13, 2021

Human trials are set to begin on two new COVID-19 vaccines under development at McMaster University in Hamilton. The vaccine boosters are inhaled using a nebulizer and have three antigens, possibly increasing their effectiveness.